• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C反应蛋白是社区获得性肺炎严重程度的独立预测指标。

C-reactive protein is an independent predictor of severity in community-acquired pneumonia.

作者信息

Chalmers James D, Singanayagam Aran, Hill Adam T

机构信息

Department of Respiratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, Scotland, UK.

出版信息

Am J Med. 2008 Mar;121(3):219-25. doi: 10.1016/j.amjmed.2007.10.033.

DOI:10.1016/j.amjmed.2007.10.033
PMID:18328306
Abstract

BACKGROUND

C-reactive protein (CRP) is an acute phase protein synthesized by the liver primarily in response to interleukin-6. Initial studies have suggested that inflammatory markers may have a role in predicting severity. We investigated whether admission and day 4 CRP could predict severity in community-acquired pneumonia.

METHODS

A prospective study was carried out over a 2-year period in a large teaching hospital. CRP was measured on admission and on day 4. The outcomes of interest were: 30-day mortality; need for mechanical ventilation and/or inotropic support; development of complicated pneumonia (lung abscess, empyema, or complicated parapneumonic effusion); the value of predictive tests were assessed using multivariate logistic regression.

RESULTS

There were 570 patients included in the study; 30-day mortality was 9.6%. Low CRP levels showed a high negative predictive value for excluding 30-day mortality (CRP <10 mg/L=100%, CRP <50=99.1%, CRP <100=98.9%, CRP <200=94.9%). Low admission CRP levels <100 mg/L were independently associated with reduced 30-day mortality (odds ratio [OR] 0.18; 0.04-0.85), P=.03; need for mechanical ventilation and/or inotropic support (OR 0.21; 0.14-0.4), P=.002; and complicated pneumonia (OR 0.05; 0.01-0.35), P=.003. A CRP that fails to fall by 50% or more within 4 days of admission is independently associated with increased 30 day mortality (OR 24.5; 6.4-93.4), P <.0001; need for mechanical ventilation and/or inotropic support (OR 7.1; 2.8-17.8), P <.0001 and complicated pneumonia (OR 15.4; 6.32-37.6), P <.0001.

CONCLUSIONS

Admission CRP <100 mg/L has reduced risk for 30-day mortality, need for mechanical ventilation and/or inotropic support, and complicated pneumonia. Failure of CRP to fall by 50% or more at day 4 leads to an increased risk for 30-day mortality, need for mechanical ventilation and/or inotropic support, and complicated pneumonia. C-reactive protein is an independent marker of severity in community-acquired pneumonia.

摘要

背景

C反应蛋白(CRP)是肝脏主要在白细胞介素-6的刺激下合成的一种急性期蛋白。初步研究表明,炎症标志物可能在预测疾病严重程度方面发挥作用。我们研究了入院时及第4天的CRP水平是否能够预测社区获得性肺炎的严重程度。

方法

在一家大型教学医院进行了一项为期2年的前瞻性研究。在入院时及第4天测量CRP水平。感兴趣的结局包括:30天死亡率;是否需要机械通气和/或使用血管活性药物支持;是否发生复杂性肺炎(肺脓肿、脓胸或复杂性类肺炎性胸腔积液);使用多因素逻辑回归评估预测指标的价值。

结果

本研究共纳入570例患者;30天死亡率为9.6%。低CRP水平对排除30天死亡率具有较高的阴性预测价值(CRP<10mg/L时为100%,CRP<50时为99.1%,CRP<100时为98.9%,CRP<200时为94.9%)。入院时CRP水平<100mg/L与30天死亡率降低独立相关(比值比[OR]0.18;0.04-0.85),P=0.03;与需要机械通气和/或血管活性药物支持相关(OR 0.21;0.14-0.4),P=0.002;与复杂性肺炎相关(OR 0.05;0.01-0.35),P=0.003。入院后4天内CRP未能下降50%或更多与30天死亡率增加独立相关(OR 24.5;6.4-93.4),P<0.0001;与需要机械通气和/或血管活性药物支持相关(OR 7.1;2.8-1

相似文献

1
C-reactive protein is an independent predictor of severity in community-acquired pneumonia.C反应蛋白是社区获得性肺炎严重程度的独立预测指标。
Am J Med. 2008 Mar;121(3):219-25. doi: 10.1016/j.amjmed.2007.10.033.
2
Prior statin use is associated with improved outcomes in community-acquired pneumonia.先前使用他汀类药物与社区获得性肺炎的预后改善相关。
Am J Med. 2008 Nov;121(11):1002-1007.e1. doi: 10.1016/j.amjmed.2008.06.030.
3
Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.社区获得性肺炎患者入院时并发复杂性类肺炎性胸腔积液和脓胸的危险因素。
Thorax. 2009 Jul;64(7):592-7. doi: 10.1136/thx.2008.105080. Epub 2009 Jan 8.
4
Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.需要机械通气的社区获得性肺炎的预后因素及结局
J Crit Care. 2005 Sep;20(3):230-8. doi: 10.1016/j.jcrc.2005.05.010.
5
Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia.C 反应蛋白在评估社区获得性肺炎疾病严重程度和并发症中的应用。
Clin Microbiol Infect. 2009 Nov;15(11):1026-32. doi: 10.1111/j.1469-0691.2009.02856.x. Epub 2009 Jun 22.
6
Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia.在社区获得性肺炎中,收缩压在预测预后方面优于其他血流动力学指标。
Thorax. 2008 Aug;63(8):698-702. doi: 10.1136/thx.2008.095562. Epub 2008 May 20.
7
Admission D-dimer can identify low-risk patients with community-acquired pneumonia.入院时的D-二聚体可识别社区获得性肺炎的低风险患者。
Ann Emerg Med. 2009 May;53(5):633-8. doi: 10.1016/j.annemergmed.2008.12.022. Epub 2009 Feb 7.
8
Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.白蛋白和 C 反应蛋白对社区获得性肺炎患者具有预后意义。
J Crit Care. 2011 Jun;26(3):287-94. doi: 10.1016/j.jcrc.2010.10.007. Epub 2010 Dec 3.
9
The prognostic value of C-reactive protein in long-term care patients requiring prolonged mechanical ventilation.C反应蛋白在需要长期机械通气的长期护理患者中的预后价值。
Chron Respir Dis. 2009;6(3):149-55. doi: 10.1177/1479972309104660.
10
C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.C 反应蛋白与老年社区获得性肺炎住院患者肺炎严重程度及死亡率的关系
Age Ageing. 2009 Nov;38(6):693-7. doi: 10.1093/ageing/afp164. Epub 2009 Sep 3.

引用本文的文献

1
Comparative Prognostic Accuracy of Clinical and Inflammation- or Nutrition-Based Scores in Older Adults with Community-Acquired Pneumonia.社区获得性肺炎老年患者中临床评分与基于炎症或营养的评分的比较预后准确性
Int J Gen Med. 2025 Aug 27;18:4811-4824. doi: 10.2147/IJGM.S540730. eCollection 2025.
2
ICU 'Magic Numbers': The Role of Biomarkers in Supporting Clinical Decision-Making.重症监护病房的“神奇数字”:生物标志物在支持临床决策中的作用
Diagnostics (Basel). 2025 Apr 11;15(8):975. doi: 10.3390/diagnostics15080975.
3
CORR Insights®: CD177, MYBL2, and RRM2 Are Potential Biomarkers for Musculoskeletal Infections.
CORR见解®:CD177、MYBL2和RRM2是肌肉骨骼感染的潜在生物标志物。
Clin Orthop Relat Res. 2025 Jun 1;483(6):1072-1074. doi: 10.1097/CORR.0000000000003443. Epub 2025 Mar 4.
4
Advantages of short-term antimicrobial treatment for pneumonia and aspiration pneumonia in older patients aged over 65: A nationwide inpatient database study.65岁以上老年患者肺炎和吸入性肺炎短期抗菌治疗的优势:一项全国性住院患者数据库研究。
Glob Health Med. 2025 Feb 28;7(1):28-38. doi: 10.35772/ghm.2024.01087.
5
Endothelial Biomarkers Are Superior to Classic Inflammatory Biomarkers in Community-Acquired Pneumonia.内皮生物标志物在社区获得性肺炎中优于经典炎症生物标志物。
Biomedicines. 2024 Oct 21;12(10):2413. doi: 10.3390/biomedicines12102413.
6
Serum activin A as a prognostic biomarker for community acquired pneumonia.血清激活素A作为社区获得性肺炎的预后生物标志物
World J Clin Cases. 2024 Aug 6;12(22):5016-5023. doi: 10.12998/wjcc.v12.i22.5016.
7
Perceptions of C-reactive Protein Measurement Among General Physicians: A Qualitative Study on Diagnostic Value, Clinical Dilemmas, and Professional Growth.普通内科医生对C反应蛋白测量的认知:关于诊断价值、临床困境及职业成长的定性研究
Cureus. 2024 Jul 2;16(7):e63695. doi: 10.7759/cureus.63695. eCollection 2024 Jul.
8
Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes.靶向炎症的新机遇:心肌梗死和 2 型糖尿病。
Cardiovasc Res. 2024 Sep 21;120(11):1241-1252. doi: 10.1093/cvr/cvae142.
9
Biomarkers in pulmonary infections: a clinical approach.肺部感染中的生物标志物:临床应用方法。
Ann Intensive Care. 2024 Jul 17;14(1):113. doi: 10.1186/s13613-024-01323-0.
10
Spectrum and antimicrobial resistance in acute exacerbation of chronic obstructive pulmonary disease with pneumonia: a cross-sectional prospective study from Vietnam.越南一项横断面前瞻性研究:慢性阻塞性肺疾病急性加重合并肺炎的谱和抗菌药物耐药性。
BMC Infect Dis. 2024 Jun 23;24(1):622. doi: 10.1186/s12879-024-09515-6.